These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 7492599)
21. Symmetric fluoro-substituted diol-based HIV protease inhibitors. Ortho-fluorinated and meta-fluorinated P1/P1'-benzyloxy side groups significantly improve the antiviral activity and preserve binding efficacy. Lindberg J; Pyring D; Löwgren S; Rosenquist A; Zuccarello G; Kvarnström I; Zhang H; Vrang L; Classon B; Hallberg A; Samuelsson B; Unge T Eur J Biochem; 2004 Nov; 271(22):4594-602. PubMed ID: 15560801 [TBL] [Abstract][Full Text] [Related]
22. Quantitative structure-activity relationship of some HIV-1 protease inhibitors: a Fujita-Ban type analysis. Mekapati SB; Sivakumar R; Gupta SP J Enzyme Inhib; 2001; 16(3):185-97. PubMed ID: 11697040 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands. Yang ZH; Bai XG; Zhou L; Wang JX; Liu HT; Wang YC Bioorg Med Chem Lett; 2015 May; 25(9):1880-3. PubMed ID: 25838144 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 protease: the rigidity perspective. Heal JW; Jimenez-Roldan JE; Wells SA; Freedman RB; Römer RA Bioinformatics; 2012 Feb; 28(3):350-7. PubMed ID: 22291339 [TBL] [Abstract][Full Text] [Related]
25. Inhibitors of HIV protease: unique non-peptide active site templates. Tait BD; Domagala J; Ellsworth EL; Ferguson D; Gajda C; Hupe D; Lunney EA; Tummino PJ J Mol Recognit; 1996; 9(2):139-42. PubMed ID: 8877805 [TBL] [Abstract][Full Text] [Related]
26. Enhanced replication of R5 HIV-1 isolates in vitro by a small-molecule reagent targeting HIV-1 protease. Wardle NJ; Hudson HR; Matthews RW; Nunn CM; Vella C; Bligh SW ChemMedChem; 2013 May; 8(5):719-21. PubMed ID: 23509042 [TBL] [Abstract][Full Text] [Related]
29. Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling. Thanki N; Rao JK; Foundling SI; Howe WJ; Moon JB; Hui JO; Tomasselli AG; Heinrikson RL; Thaisrivongs S; Wlodawer A Protein Sci; 1992 Aug; 1(8):1061-72. PubMed ID: 1304383 [TBL] [Abstract][Full Text] [Related]
30. QSAR studies on HIV-1 protease inhibitors using non-linearly transformed descriptors. Saranya N; Selvaraj S Curr Comput Aided Drug Des; 2012 Mar; 8(1):10-49. PubMed ID: 21999608 [TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors. Yan J; Huang N; Li S; Yang LM; Xing W; Zheng YT; Hu Y Bioorg Med Chem Lett; 2012 Mar; 22(5):1976-9. PubMed ID: 22306123 [TBL] [Abstract][Full Text] [Related]
32. Switching between allosteric and dimerization inhibition of HIV-1 protease. Bowman MJ; Byrne S; Chmielewski J Chem Biol; 2005 Apr; 12(4):439-44. PubMed ID: 15850980 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of the substrate envelope hypothesis for inhibitors of HIV-1 protease. Chellappan S; Kairys V; Fernandes MX; Schiffer C; Gilson MK Proteins; 2007 Aug; 68(2):561-7. PubMed ID: 17474129 [TBL] [Abstract][Full Text] [Related]
34. Anti HIV-1 agents 6. Synthesis and anti-HIV-1 activity of indolyl glyoxamides. Wang Y; Huang N; Yu X; Yang LM; Zhi XY; Zheng YT; Xu H Med Chem; 2012 Sep; 8(5):831-3. PubMed ID: 22741604 [TBL] [Abstract][Full Text] [Related]
35. Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS. Ghosh AK; Osswald HL; Prato G J Med Chem; 2016 Jun; 59(11):5172-208. PubMed ID: 26799988 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of new simple indolic non peptidic HIV Protease inhibitors: the effect of different substitution patterns. Bonini C; Chiummiento L; Di Blasio N; Funicello M; Lupattelli P; Tramutola F; Berti F; Ostric A; Miertus S; Frecer V; Kong DX Bioorg Med Chem; 2014 Sep; 22(17):4792-802. PubMed ID: 25074848 [TBL] [Abstract][Full Text] [Related]
37. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir. Lefebvre E; Schiffer CA AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715 [TBL] [Abstract][Full Text] [Related]